D.A. Davidson & Co. Moderna, Inc. Transaction History

D.A. Davidson & Co.

$12 Billion
Q3 2024

A detailed history of D.A. Davidson & Co. transactions in Moderna, Inc. stock. As of the latest transaction made, D.A. Davidson & Co. holds 39,937 shares of MRNA stock, worth $1.47 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

39,937

Previous 34,372 16.19%

Holding current value

$1.47 Million

Previous $4.08 Million 34.62%

% of portfolio

0.02%

Previous 0.04%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$63.64 - $125.14 $354,156 - $696,404	5,565 Added 16.19%	39,937 $2.67 Million
Q2 2024 Jul 31, 2024	SELL	$101.21 - $166.61 $158,798 - $261,411	-1,569 Reduced 4.37%	34,372 $4.08 Million
Q1 2024 May 13, 2024	BUY	$85.37 - $115.44 $242,450 - $327,849	2,840 Added 8.58%	35,941 $3.83 Million
Q4 2023 Feb 09, 2024	BUY	$69.51 - $104.43 $1.6 Million - $2.4 Million	22,988 Added 227.31%	33,101 $3.29 Million
Q3 2023 Nov 08, 2023	BUY	$96.41 - $126.61 $79,731 - $104,706	827 Added 8.91%	10,113 $1.04 Million
Q2 2023 Aug 10, 2023	BUY	$118.5 - $160.53 $40,527 - $54,901	342 Added 3.82%	9,286 $1.13 Million
Q1 2023 Apr 25, 2023	SELL	$135.66 - $197.02 $805,413 - $1.17 Million	-5,937 Reduced 39.9%	8,944 $1.37 Million
Q4 2022 Feb 03, 2023	BUY	$118.38 - $210.04 $853,283 - $1.51 Million	7,208 Added 93.94%	14,881 $2.67 Million
Q3 2022 Nov 07, 2022	BUY	$118.07 - $194.18 $2,951 - $4,854	25 Added 0.33%	7,673 $907,000
Q2 2022 Jul 28, 2022	BUY	$117.13 - $176.59 $48,374 - $72,931	413 Added 5.71%	7,648 $1.09 Million
Q1 2022 May 12, 2022	BUY	$126.46 - $235.05 $11,634 - $21,624	92 Added 1.29%	7,235 $1.25 Million
Q4 2021 Jan 31, 2022	BUY	$225.82 - $368.51 $361,312 - $589,616	1,600 Added 28.87%	7,143 $1.81 Million
Q3 2021 Nov 15, 2021	BUY	$221.9 - $484.47 $142,681 - $311,514	643 Added 13.12%	5,543 $2.13 Million
Q2 2021 Aug 10, 2021	SELL	$129.91 - $234.98 $17,018 - $30,782	-131 Reduced 2.6%	4,900 $1.15 Million
Q1 2021 May 07, 2021	SELL	$109.18 - $185.98 $238,776 - $406,738	-2,187 Reduced 30.3%	5,031 $659,000
Q4 2020 Feb 10, 2021	BUY	$65.74 - $169.86 $474,511 - $1.23 Million	7,218 New	7,218 $754,000

Others Institutions Holding MRNA

# of Institutions

954

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

News

Stay updated on D.A. Davidson & Co. with notifications on news.

Account